US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist
  • 4.840
  • +0.140+2.98%
Close Jan 2 16:00 ET
  • 4.820
  • -0.020-0.41%
Post 17:05 ET
261.06MMarket Cap-16.69P/E (TTM)

About Fulcrum Therapeutics Company

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The firm develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.

Company Profile

SymbolFULC
Company NameFulcrum Therapeutics
Listing DateJul 18, 2019
Issue Price16.00
Founded2015
CEOMr. Alex C. Sapir
MarketNASDAQ
Employees76
Fiscal Year Ends12-31
Address26 Landsdowne Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-651-8851
Websitehttp://www.fulcrumtx.com

Company Executives

  • Name
  • Position
  • Salary
  • Alex C. Sapir
  • Director, President and Chief Executive Officer
  • 6.99M
  • Dr. Patrick Taylor Horn, M.D.,PhD.
  • Chief Medical Officer
  • --
  • Alan A. Musso
  • Chief Financial Officer and Treasurer
  • 1.88M
  • Curtis G. Oltmans
  • Chief Legal Officer
  • 2.32M
  • Gregory Tourangeau
  • Vice President, Finance, Controller and Principal Accounting Officer
  • --
  • Melvin H. Hayes, III
  • Executive Vice President, Patient Experience
  • 2.19M
  • Kate Haviland
  • Chairman of the Board
  • 157.90K
  • Dr. Robert J. Gould, PhD
  • Director
  • 424.50K
  • Sonja Banks
  • Independent Director
  • 121.40K
  • Colin Hill
  • Independent Director
  • --
  • Katina Dorton, J.D.,M.B.A.
  • Independent Director
  • 136.40K
  • Dr. Alan Ezekowitz, D.Phil.,MB.Ch.B.
  • Independent Director
  • 131.40K
  • Rachel King
  • Independent Director
  • --
  • James A. Geraghty
  • Independent Director
  • 131.90K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
+3.79%
Coinbase
COIN
+3.59%
MicroStrategy
MSTR
+3.59%
Petroleo Brasileiro SA Petrobras
PBR
+2.95%
MARA Holdings
MARA
+2.62%

Unlock the Full List